Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05152459
Title Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

follicular lymphoma

Therapies

Tazemetostat + Ublituximab + Umbralisib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center Duarte California 91010 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field